Quantcast
Last updated on April 23, 2014 at 15:59 EDT

Latest Smith, Kline & French Stories

2010-03-30 15:05:00

CAMBRIDGE, Mass., March 30 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that it has appointed Tamar D. Howson to its Board of Directors. Ms. Howson is currently a Partner at JSB-Partners, a transaction advisory firm serving the life sciences industry. Ms. Howson has extensive experience in licensing, collaborations and M&A...

2010-03-29 11:29:00

LONDON and PHILADELPHIA, March 29 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced today that it has re-submitted the supplemental New Drug Application (sNDA) for Avodart® (dutasteride) for prostate cancer risk reduction among men at increased risk of developing the disease to the US Food and Drug Administration (FDA). The re-submission provides an update to the initial application in 2009. The withdrawal of the initial application was not the result of...

2010-03-29 08:48:00

WEST PALM BEACH, Fla., March 29 /PRNewswire/ -- The Cosmetic Bootcamp is pleased to announce an expanded program for its June 2010 meeting at The Broodmoor in Colorado Springs. Included in the programs are new techniques for injecting soft tissue augmentation products, botulinum toxins and volumizing materials. Symposia about new laser technologies for rejuvenation and fat treatments, chemical peels, recognition and treatment of complications, novel cosmeceutical and effective marketing...

2010-03-03 15:40:00

GlaxoSmithKline Continues to Blame Patients Crippled by Poligrip HOUSTON, March 3 /PRNewswire-USNewswire/ -- Pharmaceutical giant, GlaxoSmithKline (GSK), has taken the extraordinary step of warning doctors about the dangers posed by its denture cream, while continuing to blame and mislead patients crippled by its products. On February 18, the company announced that it would remove zinc from all of its denture adhesive products, citing concerns about the "safety and health" of its...

e8f328d81444e1c5275ceca696261f0a1
2010-02-19 11:08:24

Because the safety and health of our consumers is our primary concern, GlaxoSmithKline (GSK) Consumer Healthcare is issuing a Consumer Advisory warning consumers about the potential health risks associated with long-term excessive use of zinc-containing denture adhesives. GSK has taken voluntary, precautionary action to end the manufacture and supply of its zinc-containing denture adhesives marketed across many countries. We are taking these actions because we have become aware of potential...

2010-02-18 11:55:00

Untold Numbers of Consumers Still Left Disabled By Its Products WASHINGTON, Feb. 18 /PRNewswire-USNewswire/ -- GlaxoSmithKline, the maker of popular denture adhesives Poligrip and Super Poligrip, announced today that it will remove zinc from all of its denture adhesive products. The pharmaceutical giant has added the potentially hazardous mineral to its adhesives for decades, despite overwhelming evidence that consuming large quantities of zinc over an extended period of time can cause...

2010-02-01 13:58:00

PHILADELPHIA, Feb. 1 /PRNewswire-FirstCall/ -- On Thursday, February 4, 2010, GlaxoSmithKline plc will announce its full year financial results for the year ended December 31, 2009. It is anticipated that the announcement will be released to the London Stock Exchange at approximately 7:00am Eastern Standard Time (EST) and available at www.gsk.com. Following the announcement, Andrew Witty, Chief Executive Officer, and Julian Heslop, Chief Financial Officer, will hold a briefing meeting for...

2009-12-22 08:11:00

CINCINNATI, Dec. 22 /PRNewswire/ -- Prasco Laboratories announced today that they have signed a distribution and supply agreement with Stiefel Laboratories, Inc., a GlaxoSmithKline company, for Clobetasol Propionate Foam 0.05%, the latest product in Prasco's line of authorized generics. Under the terms of the agreement, Prasco will market and distribute Clobetasol Propionate Foam 0.05% in 50g and 100g canisters in the U.S. under the Prasco label. "We are pleased to provide pharmacists and...

2009-12-16 09:11:00

PARSIPPANY, N.J. and ANN ARBOR, Mich., Dec. 16 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc [GSK] (NYSE: GSK) and NanoBio Corporation today announced an exclusive licensing agreement in the United States and Canada for the over-the-counter (OTC) use of NB-001, a novel, patented compound representing the next advance in the treatment of cold sores. Developed by NanoBio, NB-001 provides significant antimicrobial activity against the virus that causes cold sores, herpes labialis. Cold...

2009-11-02 04:28:00

DUBLIN, Ireland, November 2 /PRNewswire-FirstCall/ -- The Board of Directors of Shire plc (LSE: SHP, NASDAQ: SHPGY) announces that Mr David Stout joined the Board as a Non Executive Director with effect from 31 October 2009. Mr Stout has extensive pharmaceutical experience. Most recently he was President, Pharmaceutical Operations at GSK. In this position he had responsibility for pharmaceutical operations in the United States, Europe, Japan and all other International Markets. Mr...